CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
40 hedge funds and large institutions have $61M invested in CTI BioPharma Corp. (DE) Common Stock in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
-7
Holders Change %
-14.89%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
9
Reduced
9
Closed
13
Calls
$297K
Puts
–
Net Calls
+$297K
Net Calls Change
-$2K
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$16.6M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$13.6M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$7.56M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.54M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$830K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$668K |
| 2 |
Jane Street
New York
|
-$233K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$196K |
| 4 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
-$183K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$181K |
